Robbie G. Majzner - Concepedia

Author

Robbie G. Majzner

Also Known As

Majzner, Robbie G, R Majzner, R. G. Majzner, R. Majzner, Robbie G Majzner, Robbie G. Majzner, Robbie Majzner, Y Natkunam

233

Publications

12.3K

Citations

H-Index

Concepts

All Affiliations

Stanford University Parker Institute for Cancer Immunotherapy Stanford Medicine National Cancer Institute Center for Cancer Research

About

Robbie G. Majzner is an author at Stanford University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	3.8K
2	Cell Biology	8	8	2.2K
3	Engineering	1	1	193
4	Allergy	1	1	1.3K
5	Biomedical Engineering	1	1	193

Robbie G. Majzner

Publications

Citations

H-Index

Page 1

	Year	Citations
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy Terry J. Fry, Nirali N. Shah, Rimas J. Orentas, Nature Medicine AllergyAutoimmune DiseaseCd19-targeted Car ImmunotherapyAdaptive Immune SystemT-regulatory Cell	2017	1.3K
c-Jun overexpression in CAR T cells induces exhaustion resistance Rachel C. Lynn, Evan W. Weber, Elena Sotillo, Nature PhysiologyAutoimmunityTolerance InductionImmunotherapyMedicine	2019	831
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom, Nature	2022	737
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors Robbie G. Majzner, Johanna Theruvath, Anandani Nellan, Clinical Cancer Research	2019	637
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling Evan W. Weber, Kevin R. Parker, Elena Sotillo, Science	2021	558
Tuning the Antigen Density Requirement for CAR T-cell Activity Robbie G. Majzner, Skyler P. Rietberg, Elena Sotillo, Cancer Discovery	2020	537
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial Jay Y. Spiegel, Shabnum Patel, Lori Muffly, Nature Medicine	2021	537
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas Christopher Mount, Robbie G. Majzner, Shree Sundaresh, Nature Medicine Neuro-oncologyCancer ImmunosurveillanceGliomaMedicineImmunology	2018	476
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase Alec J. Walker, Robbie G. Majzner, Ling Zhang, Molecular Therapy	2017	372
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors Johanna Theruvath, Elena Sotillo, Christopher Mount, Nature Medicine Cancer ImmunosurveillanceMedicineImmunologyCell TransplantationCancer Treatment	2020	288

Page 1